| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 728.29 | 571.99 | 548.66 | 569.94 | 524.99 |
| Other Income | 16.29 | 12.25 | 14.39 | 6.77 | 5.85 |
| Stock Adjustments | 1.38 | 51 | -17.98 | -5.42 | -6.01 |
| Total Income | 745.96 | 635.24 | 545.07 | 571.29 | 524.83 |
| EXPENDITURE : | |||||
| Raw Materials | 232.51 | 231.52 | 155.96 | 193.65 | 194.06 |
| Excise Duty | 0 | 0.99 | 4.95 | 6.21 | 7.92 |
| Power and Fuel Cost | 8.27 | 8.3 | 7.68 | 7.43 | 8.51 |
| Other Manufacturing Expenses | 9.83 | 7.88 | 7.47 | 10.41 | 11.85 |
| Employee Cost | 197.4 | 150.39 | 162.04 | 169.35 | 159.84 |
| Selling and Administration Expenses | 198.14 | 168.54 | 144.27 | 154.91 | 141.54 |
| Miscellaneous Expenses | 12.22 | 9.08 | 11.37 | 6.16 | 6.67 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | 87.59 | 58.54 | 51.33 | 23.19 | -5.56 |
| Interest and Financial Charges | 0 | 0 | 0 | 0 | 0 |
| Profit before Depreciation and Tax | 87.59 | 58.54 | 51.33 | 23.19 | -5.56 |
| Depreciation | 14.92 | 14.74 | 15.83 | 17.43 | 15.28 |
| Profit Before Tax | 72.67 | 43.8 | 35.5 | 5.76 | -20.84 |
| Tax | 18.22 | 17.89 | 15.45 | 0.5 | 0 |
| Profit After Tax | 54.45 | 25.91 | 20.05 | 5.26 | -20.84 |
| Adjustment below Net Profit | -0.6 | -2.28 | -1.05 | 0 | 0 |
| P and L Balance brought forward | 114.37 | 90.74 | 71.74 | 20.27 | 41.11 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | 168.22 | 114.37 | 90.74 | 25.53 | 20.27 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 21.78 | 10.36 | 8.02 | 2.1 | 0 |
| Book Value | 120.32 | 98.77 | 89.15 | 62.41 | 60.3 |
| Extraordinary Items | 0.04 | 0.01 | 4.28 | 0.04 | 0 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 5 | 5 | 5 | 5 | 5 |
| Reserves and Surplus | 295.8 | 241.93 | 217.87 | 151.01 | 145.76 |
| Total Shareholders Funds | 300.8 | 246.93 | 222.87 | 156.01 | 150.76 |
| Secured Loans | 0 | 0 | 0 | 0 | 0 |
| Unsecured Loans | 2.02 | 6.66 | 2.28 | 12.92 | 1.02 |
| Total Debt | 2.02 | 6.66 | 2.28 | 12.92 | 1.02 |
| Total Liabilities | 302.82 | 253.59 | 225.15 | 168.93 | 151.78 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 119.83 | 105.85 | 102.57 | 203.76 | 191.44 |
| Less: Accum. Depreciation | 45 | 30.39 | 15.73 | 106.4 | 90.46 |
| Net Block | 74.83 | 75.46 | 86.84 | 97.36 | 100.98 |
| Capital Work in Progress | 6.9 | 3.57 | 4.81 | 6.31 | 12.21 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Current Assets, Loans and Advances | |||||
| Inventories | 118.1 | 113.15 | 57.71 | 76.73 | 86.13 |
| Sundry Debtors | 79.75 | 54.63 | 43 | 83.14 | 42.77 |
| Cash and Bank Balance | 173.3 | 125.92 | 115.58 | 76.83 | 25.08 |
| Loans and Advances | 109.98 | 89.58 | 110.89 | 62.61 | 144.41 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 223.64 | 168.38 | 160.84 | 215.71 | 222.87 |
| Provisions | 36.4 | 40.34 | 32.84 | 18.33 | 36.95 |
| Net Current Assets | 221.09 | 174.56 | 133.5 | 65.27 | 38.57 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 302.82 | 253.59 | 225.15 | 168.94 | 151.76 |
| Contingent Liabilities | 26.77 | 7.34 | 15.97 | 16.62 | 12.26 |
If I had made LUMPSUM investment of ₹ 1,00,000
in ASTRAZENECA PHARMA INDIA LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
